Traws Pharma Inc. – Filings and Transcripts

NASDAQ: TRAW
Share price (5/21/26): $1.49
Market cap (5/21/26): $22.6 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q1

ended 12/31/25 FY 2025 – amended

ended 12/31/25 FY 2025

Late annual filing notification for FY 2025

ended 09/30/25 Q3

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Prospectus supplement

Shelf registration

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Ownership Filter

Squadron Capital Management LLC

Perceptive Advisors LLC

Orbimed Advisors LLC

Orbimed Advisors LLC, OrbiMed Capital GP VIII LLC

Parker Charles Nolan

News Filter

Private Financing of Up to $60M Offering of Common Stock (With $10M Upfront) and Milestone-Based Warrants Expected to Support Operations Into Q1 2027

Private Financing of Up to $60M (With $10M of Such Amount Upfront) Offering of Common Stock and Milestone-Based and Three-Year Warrants Completed on April 15, 2026 Supporting Operations Into Q1 2027

Announces Up to $60 Million Private Placement Financing

PK Study of Compressed Tivoxavir Marboxil Tablets Submitted Under Open IND in Australia and Preparations Are Underway for a Human Influenza Prophylaxis Challenge Study in the UK

Completes Enrollment of Ratutrelvir Clinical Study in PAXLOVID®-Eligible and Ineligible COVID-19 Patients; Announces Plans for Added Indication for Tivoxavir Marboxil as a Prophylactic Treatment for Seasonal Influenza

Proxies Filter

Preliminary proxy

Additional info about upcoming vote

Definitive proxy

Definitive proxy

Preliminary proxy

Other Filter

Notice of effectiveness

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC